详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Jiang, Qian[1] * ; Li, Zongru[1] ; Hou, Yue[1] ; Hu, Yu[2] ; Li, Weiming[2] ; Liu, Xiaoli[3] ; Xu, Na[3] ; Zhang, Yanli[4] ; Song, Yongping[4] ; Meng, Li[5] ; Hong, Zhenya[5]

; Liu, Bingcheng[6] ; Li, Yan[7] ; Chen, Suning[8] ; Xue, Mengxing[9] ; Zhu, Huanling[10] ; Li, He[10] ; Du, Xin[11] ; Lou, Jin[11] ; Zhang, Xiaohan[11] ; Liang, Yang[12] ; Dai, Yu-Jun[12] ; Chen, Zi[13] ; Niu, Qian[13] ; Men, Lichuang[13] ; Yang, Dajun[13,14] ; Zhai, Yifan[14,15] ; Huang, Xiao-Jun[1] ;

单位： [1]Peking Univ, Peking Univ Peoples Hosp, Inst Hematol, Beijing, Peoples R China [2]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China [3]Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China [4]Zhengzhou Univ, Dept Hematol, Affiliated Canc Hosp, Zhengzhou, Peoples R China [5]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China [6]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China [7]Natl Clin Res Ctr Blood Dis, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China [8]Soochow Univ, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou, Peoples R China [9]Soochow Univ, Dept Hematol, Affiliated Hosp 1, Suzhou, Peoples R China [10]Sichuan Univ, Dept Hematol, West China Hosp, Chengdu, Peoples R China [11]Shenzhen Univ, Shenzhen Peoples Hosp 2, Div Hematol, Affiliated Hosp 1, Shenzhen, Peoples R China [12]Sun Yat Sen Univ, Partment Hematol Oncol, Canc Ctr, Guangzhou, Peoples R China [13]Guangzhou Healthquest Pharma Co Ltd, Guangzhou, Peoples R China [14]Ascentage Pharma Grp Inc, Rockville, MD USA [15]Healthquest Pharma Co Ltd, Guangzhou, Peoples R China

出处：

DOI：

ISSN：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 1 区

医学

小类 | 1 区血液学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区血液学

JCR分区：

出版当年[2020]版：

Q1 HEMATOLOGY

最新[2023]版：

Q1 HEMATOLOGY

第一作者：

第一作者单位： [1]Peking Univ, Peking Univ Peoples Hosp, Inst Hematol, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Updated Results of Pivotal Phase 2 Trials of Olverembatinib (HQP1351) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic- and Accelerated-Phase Chronic Myeloid Leukemia (CML-CP and CML-AP) with T315I Mutation

文献详情